Skip to main content

#153382

Anti-CEA [365]

Cat. #153382

Anti-CEA [365]

Cat. #: 153382

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 10-12 weeks

Target: CEA

Class: Monoclonal

Application: ELISA

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Lindy Durrant

Institute: University of Nottingham

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-CEA [365]
  • Alternate name: CEACAM5; CEA
  • Research fields: Cancer;Cell signaling and signal transduction
  • Clone: 365
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Reactivity: Human
  • Host: Mouse
  • Application: ELISA
  • Description: Cell surface glycoprotein that plays a role in cell adhesion and in intracellular signaling. Receptor for E.coli Dr adhesins, found in adenocarcinomas of endodermally derived digestive system epithelium and fetal colon. Belongs to the immunoglobulin superfamily, CEA family- contains 7 Ig-like (immunoglobulin-like) domains.
  • Immunogen: KLH conjugated synthetic peptide derived from human CEA
  • Isotype: IgG1

Target Details

  • Target: CEA
  • Target background: Cell surface glycoprotein that plays a role in cell adhesion and in intracellular signaling. Receptor for E.coli Dr adhesins, found in adenocarcinomas of endodermally derived digestive system epithelium and fetal colon. Belongs to the immunoglobulin superfamily, CEA family- contains 7 Ig-like (immunoglobulin-like) domains.

Applications

  • Application: ELISA

Handling

  • Format: Liquid
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -20° C
  • Shipping conditions: Dry ice

References

  • Spendlove et al. 1999. Cancer Res. 59(10):2282-6. PMID: 10344729.
  • Decay accelerating factor (CD55): a target for cancer vaccines?

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.